Frontlight ResearchEarly access
Peripheral artery disease trials in Australia
6 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Box Hill, Brisbane, Canberra, Geelong, Meadowbrook, Perth, Southport, St Leonards
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Box Hill, Perth
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Bundaberg, Cairns, Clayton, Heidelberg, Liverpool, Murdoch, Nambour, Parkville, Saint Leonards, Southport, St Albans, Sydney, Urraween, Wahroonga, Westmead, Wollongong, Woolloongabba
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleThe GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Where
- Adelaide, Nedlands, Randwick
- Age
- 18 years and over
- People
- 244 worldwide
- Run by
- W.L.Gore & Associates
See details and how to joinNCT05811364 - No phaseTaking peopleThe Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
- Where
- Canberra, Melbourne, Sydney
- People
- 100 worldwide
- Run by
- Efemoral Medical, Inc.
See details and how to joinNCT04584632 - No phaseTaking peopleEvaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia
- Where
- Randwick
- Age
- 18 years and over
- People
- 30
- Run by
- R3 Vascular Inc.
See details and how to joinNCT06075940